Severe Asthma Online Monograph
Release Date: May 7, 2010
Expiration Date: May 7, 2012
 |
||
 |
||
|
How to Obtain AMA PRA
|
|
 |
||
Estimated Time of Completion: 30 minutes
Description
The focus of this educational program is to present an evidence-based review of research on more severe asthma disease and analyze treatment options for these patients. Experts in asthma specialties will review the most germane published data and evaluate their implications for the diagnosis and treatment of asthma. Talks are presented on the biologic and pathophysiologic understandings of asthma, characteristics and classification of asthma, and treatment strategies.
Objectives
After completing this educational activity, participants will be able to do the following:
- Describe advances in diagnostic procedures for differentiating severity classifications of asthma.
- Compare and contrast the safety and efficacy of therapeutic options for asthma.
- Report results from clinical trials investigating experimental therapies for asthma and discuss their potential roles in management strategies.
Target Audience
This activity is directed to pulmonologists, allergists, internists, family practitioners, and other allied health practitioners who deal with areas of respiratory care and will find this course valuable in their clinical practice.
Accreditation
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.
Activity Directors / Planning Committee
Serpil C. Erzurum, MD
Chair, Department of Pathobiology, Lerner Research Institute
Co-Director, Asthma Center, Respiratory Institute
Cleveland Clinic
Cleveland, OH
Thomas R. Gildea, MD, MS, FCCP
Head, Section of Bronchoscopy
Department of Pulmonary, Allergy and Critical Care Medicine and Transplant Center
Respiratory Institute
Cleveland Clinic
Cleveland, OH
| Mark A. Aronica, MD Department of Pulmonary, Allergy and Critical Care Medicine Respiratory Institute Cleveland Clinic Cleveland, OH |
Serpil C. Erzurum, MD Chair, Department of Pathobiology Lerner Research Institute Co-Director, Asthma Center Respiratory Institute Cleveland Clinic Cleveland, OH |
Thomas R. Gildea, MD, MS, FCCP Head, Section of Bronchoscopy Department of Pulmonary, Allergy and Critical Care Medicine and Transplant Center Respiratory Institute Cleveland Clinic Cleveland, OH |
Disclosure
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty members have indicated that they may have a relationship which, in the context of their presentations, could be perceived as a potential conflict of interest:
| Mark A. Aronica, MD | ||
| Independent Contractor: | Asthmatx, Inc. | |
| Serpil C. Erzurum, MD | ||
| Independent Contractor: | Asthmatx, Inc. | |
| Thomas R. Gildea, MD | ||
| Investigator: | Asthmatx, Inc. | |
This CME activity was produced by The Cleveland Clinic Foundation
Respiratory Institute and the Center for Continuing Education.
